Health

Cerebral, Robotic Research, ABclonal Technology, Ola and RainMed Medical all pulled in nine-figure rounds, the first two featuring SoftBank Vision Fund 2.

Q&A with John Banta, president and managing director, Blue Venture Fund

The cancer diagnostics technology developer raised $300m from investors also including Kaiser Permanente, Intermountain, Novartis and Roche, but its machine learning model points to where GV is increasingly active.

Incode and Odyssey Therapeutics each secured over $200m while Alvotech Holdings, BenevolentAI and Tomorrow.io have agreed reverse mergers at unicorn valuations.

Since its passage, the Bayh-Dole Act has bolstered US economic output by up to $1.7 trillion, supported 5.9 million jobs and helped lead to more than 14,000 spinouts.

Professional education provider Platzi pulled in $60m through a Prosus-led round while e-commerce software producer Marketplacer took in $38m from investors including Salesforce Ventures.

The semiconductor producer completed a nine-figure series C round from investors including SAIC Motor. This is a deal from the semiconductor and chips space, which does not normally see many corporate-backed deals but our data suggest valuations are currently experiencing upward pressure.

SoftBank’s Latin America Fund helped prayer app developer Glorify raise $40m at a $250m valuation while decentralised derivatives network Hxro Network secured $34m in a round featuring several corporates.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

AviadoBio is focusing on neurodegenerative diseases and has emerged from stealth with nearly $100m in total from investors including Johnson & Johnson Innovation – JJDC.

Spun out of King’s College London, AviadoBio is focusing on neurodegenerative diseases and has emerged from stealth with nearly $100m in overall funding.